AstraZeneca PLC is 77.4x more valuable than Edgewise Therapeutics, Inc. by market capitalization ($286.27 B vs $3.70 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EWTX | AZN |
|---|---|---|
| Market cap | $3.70 B | $286.27 B |
| US-listed rank | #1641 | #45 |
| Net income (latest FY) | -$167.79K | - |
| SEC filings | 384 | 1,004 |
AstraZeneca PLC is 77.4x more valuable than Edgewise Therapeutics, Inc. by market capitalization ($286.27 B vs $3.70 B).
Full pages: Edgewise Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.